Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer

Amarin Corporation plc, a biopharmaceutical company based in Bedminster focused on the commercialization and development of therapeutics to improve cardiovascular (CV) health, announced that Aaron Berg has been promoted to the position of senior vice president, chief commercial officer. Berg previously served the company as senior vice president, Marketing and Sales. Berg joined Amarin in November of 2012 and has played a leading role in U.S. prescription and related revenue growth of the company’s lead product, Vascepa® (icosapent ethyl) capsules.

Berg is an industry veteran. Before joining Amarin, Berg served as president and chief executive officer for Essentialis, Inc., a development stage pharmaceutical company where he led the company’s work on triglyceride management. Prior to joining Essentialis, Berg served as vice president of Marketing and Sales at Kos Pharmaceuticals (Kos), where he was instrumental in driving annual revenues approaching $1 billion.  Berg worked at Kos until it was acquired by Abbott Laboratories in December 2006 for $3.7 billion. Berg began his pharmaceutical industry career as a sales representative with Bristol-Myers Squibb, followed by various commercial positions with Schering-Plough and GlaxoSmithKline.

In this expanded role, Berg will be responsible for ensuring continued commercial growth for Vascepa based on its current indication while preparing for and ensuring successful expanded promotion of Vascepa assuming positive results of the company’s landmark REDUCE-IT cardiovascular outcomes trial.  The results of this important study are anticipated before the end of Q3 2018.  The company thanked Mark Salyer, whose position is being filled by Berg, for his ideas and contributions and wishes him much success in his future endeavors.

“Aaron has made invaluable contributions to Amarin over multiple years,” said John F. Thero, president and chief executive officer of Amarin. “He has wide-ranging experience and comprehensive knowledge of our industry combined with an entrepreneurial spirit and a collaborative approach which makes him broadly respected and well-positioned to help lead Amarin in fulfilling our commercial opportunities. We are excited to work with Aaron in this important leadership position.”

To access more business news, visit njbmagazine.com

Related Articles: